SCS
ETNB

Syquant Capital SAS’s 89bio ETNB Stock Holding History

Syquant Capital SAS’s Portfolio ETNB Stock Details ETNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-2,593,694
Closed -$38.1M – 39
2025
Q3 		$38.1M Buy
+2,593,694
New +$26.4M 10.94% 3

Other funds holding ETNB

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Syquant Capital SAS's ETNB Position: Q4 2025 in Review

Syquant Capital SAS sold out of 89bio (ETNB) in Q4 2025, closing a stake of 2,593,694 shares — an estimated $38.1M sold.

Syquant Capital SAS first reported a position in ETNB in Q3 2025 and held it in 1 quarter. The position peaked at $38.1M in Q3 2025. 2 funds tracked by Wall St. Rank hold ETNB as of Q4 2025.

  • Syquant Capital SAS reported no remaining 89bio position as of Q4 2025 after selling out during the quarter.
  • Syquant Capital SAS sold 2,593,694 89bio shares in Q4 2025, an estimated $38.1M.
  • Syquant Capital SAS first reported a position in 89bio in Q3 2025 and held it in 1 quarter.
  • Syquant Capital SAS's 89bio position peaked at $38.1M in Q3 2025.
  • 2 funds tracked by Wall St. Rank held 89bio as of Q4 2025.

Based on Syquant Capital SAS's 13F filing for Q4 2025, filed 13 Jan 2026.